Happy to share news of my upcoming promotion to Associate Professor of Medicine at @ou.edu starting this July. Grateful to my mentors and colleagues who helped make it happen, including those who wrote letters of support for my promotion.

Evaluation of a Remote Therapeutic Monitoring (RTM) Device and Integrated Care Platform in Outpatient Parenteral Antimicrobial Therapy (OPAT) ✅ Just Accepted 🔗 https://bit.ly/4spq9ts

Evaluation of a Remote Therapeutic Monitoring (RTM) Device and Integrated Care Platform in Outpatient Parenteral Antimicrobial Therapy (OPAT)

AbstractBackground. Unplanned healthcare utilization events, including hospital readmissions and emergency room (ER) visits, are common in patients receivi

bit.ly

Out now in @cidjournal.bsky.social my first ever investigator-initiated funded study - A pilot trial evaluating IV Ensure, a remote therapeutic monitoring device in OPAT! #IDSky #OPAT Open access thanks to @ou.edu libraries so check it out! Key highlights in 🧵 academic.oup.com/cid/advance-...

Evaluation of a Remote Therapeutic Monitoring (RTM) Device and Integrated Care Platform in Outpatient Parenteral Antimicrobial Therapy (OPAT)

AbstractBackground. Unplanned healthcare utilization events, including hospital readmissions and emergency room (ER) visits, are common in patients receivi

academic.oup.com

Come train with us! We have two open spots for ID fellowship at @ou.edu Great clinical exposure, academic tracks (TxID, healthcare admin/hospital epi, trop med/global health, CCM fellowship), 12-credit certificates covered by the program. #IDSky #TxID #MedEd medicine.ouhsc.edu/academic-dep...

Also out now in American Journal of Medical Sciences, our review of infectious complications of CAR T and BsAb, led by @ou.edu ID fellow Bradley Dye, a good primer for trainees and faculty alike! #TxID #IDSky www.amjmedsci.org/article/S000...

Infectious Complications of Chimeric Antigen Receptor T Cell Therapy and Bispecific Antibodies – A Review

Chimeric antigen receptor (CAR) T cell therapy has shifted the therapeutic landscape of hematological malignancies in the last decade, and bispecific antibodies (BsAb) are an emerging treatment for th...

amjmedsci.org

Out now in @ichejournal.bsky.social , with @ritawilson.bsky.social and others, our report on the blood culture bottle shortage last year affecting the diagnostic yield in febrile neutropenia @ou.edu #TxID #IDSky doi.org/10.1017/ice....

@bryanpwhite.bsky.social et al: In a cohort (n=127) of OPAT patients on daptomycin 7.4 mg/kg for an average of 37 days, the rate of CK elevation was 11.8% at a median of 13 days (IQR 9-16) supporting weekly lab monitoring on daptomycin for OPAT. doi.org/10.1017/ash....

Incidence and risk factors for musculoskeletal adverse effects associated with daptomycin in patients receiving outpatient parenteral antimicrobial therapy | Antimicrobial Stewardship & Healthcare Epidemiology | Cambridge Core

Incidence and risk factors for musculoskeletal adverse effects associated with daptomycin in patients receiving outpatient parenteral antimicrobial therapy - Volume 5 Issue 1

doi.org

This study offers real-world data evaluating the ePlex BCID-FP rapid identification system for yeast and found it was less sensitive than previously reported and infrequently led to de-escalation of antifungals doi.org/10.1093/jaca... @josephsassinemd.bsky.social #JACAMRNews #IDSKy

ID fellowship applicants, make sure to check out our program @ou.edu: 2 year clinical program - 3 tracks (TxID, hosp epi, trop med) - Path for crit care fellowship - 12 credit certificates in year 2 #TxID #IDSky #MedEd medicine.ouhsc.edu/academic-dep...

Out now in @jac-amr.bsky.social, our real world analysis of BCID fungal panel for diagnosis of fungemia, led by the great Emily Siegrist - Sensitivity of 94%, lower than anticipated @bryanpwhite.bsky.social @ritawilson.bsky.social #IDSky academic.oup.com/jacamr/artic...

Evaluation of a rapid identification panel for fungemia

Abstract. Bloodstream infections due to yeast are associated with a high mortality rate. There is a lack of data that evaluate the real-world sensitivity o

academic.oup.com

And part 2 is out now: How to prevent travel-related infections in the transplant recipient, check it out! @ritawilson.bsky.social @andhen25.bsky.social #IDSky #TxID journals.sagepub.com/doi/full/10....

Prevention of travel-related infections in solid organ and hematopoietic cell transplant recipients - Rita Wilson Dib, José Henao-Cordero, Joseph Sassine, Emily A. Siegrist, Nelson Iván Agudelo Higuit...

The growing population of transplant survivors receiving a solid organ transplantation (SOT) or a hematopoietic cell transplantation (HCT) and the emergence of ...

journals.sagepub.com

Joseph Sassine@josephsassinemd.bsky.social · 2y ago

How to prevent infections in the increasingly immunocompromised traveler? Part 1 (non-transplant) is out now! Stay tuned for part 2! @ritawilson.bsky.social @andhen25.bsky.social @ou.edu #IDSky #TxID journals.sagepub.com/doi/10.1177/...

Invasive fusariosis after CAR T is rare but can be consequential. Here’s our case of cutaneous fusariosis after CD19 CAR T, with @ritawilson.bsky.social @ouholter.bsky.social and others, out in @asm.org Case Reports! #TxID journals.asm.org/doi/10.1128/...

Invasive fusariosis after CD19 chimeric antigen receptor T-cell therapy | ASM Case Reports

Invasive fusariosis is a rare entity that primarily affects patients with hematological malignancies and recipients of hematopoietic cell transplants. Cases of mold infections in chimeric antigen receptor T-cell (CAR-T) therapy recipients have seldom been reported (1–6). We herein present this case of invasive fusariosis managed with combination antifungal therapy. Additionally, we provide a succinct review of cases reported in existing literature.

journals.asm.org

Had a great time in Syracuse presenting Medicine Grand Rounds earlier today on Infections after CAR T at SUNY Upstate and meeting some great ID colleagues there! #TxID

Excited to launch new tracks in our 2-year ID fellowship program @ou.edu starting July 2025: TxID, Hospital epi/healthcare admin, Trop Med/Global Health, ID/Crit Care. Tracks come with option for 12-credit certificates, covered by the program: medicine.ouhsc.edu/academic-dep... 🧵 #IDSky #TxID

How to prevent infections in the increasingly immunocompromised traveler? Part 1 (non-transplant) is out now! Stay tuned for part 2! @ritawilson.bsky.social @andhen25.bsky.social @ou.edu #IDSky #TxID journals.sagepub.com/doi/10.1177/...

Sage Journals: Discover world-class research

Subscription and open access journals from Sage, the world's leading independent academic publisher.

journals.sagepub.com

Out now, everything you need to know, that is known and not known, about herpesviruses after CAR T and BsAb, in our review with Dr Emily Siegrist and Dr Roy Chemaly! @mdanderson.bsky.social @ou.edu #IDSky #TxID www.mdpi.com/1999-4915/17...

Herpesvirus Infections After Chimeric Antigen Receptor T-Cell Therapy and Bispecific Antibodies: A Review

In this narrative review, we explore the burden and risk factors of various herpesvirus infections in patients receiving chimeric antigen receptor T-cell (CAR-T) therapy or bispecific antibodies (BsAb...

mdpi.com

Spoke to @koconews.bsky.social about norovirus, clinical presentation and preventive measures #IDSky www.koco.com/article/okla...

How Oklahomans can protect themselves from norovirus, or 'stomach bug'

A stomach bug sweeping the country has infected hundreds of patients in its path.

koco.com

T-SPOT.TB performs much better in many immunocompromised populations IMO, but historically was logistically more difficult from CA due to time-sensitive FedEx of samples to Memphis which failed a lot with winter storms. Less an issue now that Quest bought T-SPOT.

Joseph Sassine@josephsassinemd.bsky.social · 2y ago

Out now in @thetxidjournal.bsky.social! T-SPOT.TB is more likely to produce actionable results than QFT-TB in patients with cancer being screened for latent TB. #TxID #IDSky onlinelibrary.wiley.com/doi/10.1111/...

T-SPOT resulted in - fewer indeterminate results (than QFT) - more “actionable” results (than QFT) in certain immunocompromised populations #TBSky

Joseph Sassine@josephsassinemd.bsky.social · 2y ago

Out now in @thetxidjournal.bsky.social! T-SPOT.TB is more likely to produce actionable results than QFT-TB in patients with cancer being screened for latent TB. #TxID #IDSky onlinelibrary.wiley.com/doi/10.1111/...

Out now in @thetxidjournal.bsky.social! T-SPOT.TB is more likely to produce actionable results than QFT-TB in patients with cancer being screened for latent TB. #TxID #IDSky onlinelibrary.wiley.com/doi/10.1111/...

A retrospective cohort study of Gram-negative BSIs in ICU shows fever, lack of source control and time to repeat follow-up blood culture (FUBC) as risk factors for repeat positive FUBC: https://doi.org/10.1093/jacamr/dlae144 #JACAMRNews @bryanpwhite.bsky.social

Risk factors for positive follow-up blood cultures in critically ill adults with Gram-negative bacteraemia

AbstractObjectives. To evaluate the utility of follow-up blood cultures (FUBCs) for Gram-negative bloodstream infection (BSI) in ICU patients and identify

doi.org

Special theme issue in @cmijournal.bsky.social - Infections in immunocompromised hosts, edited by Dr Roy Chemaly, with a series of high yield #TxID reviews, including our review of herpesviruses after allogeneic HCT #IDSky www.clinicalmicrobiologyandinfection.com/article/S119...

Clinical Microbiology and Infection@cmijournal.bsky.social · 2y ago

January 2025 Issue is now online: www.clinicalmicrobiologyandinfection.com/issue/S1198-... #IDSky #MicroSky

Recently spoke with Health IT News about the results of our innovative trial of remote therapeutic monitoring in OPAT, how RTM helped us reduce infection-related readmissions and improve patient adherence to IV ABx #IDSky #OPAT @ou.edu www.healthcareitnews.com/news/remote-...

Remote therapeutic monitoring reduces readmissions, academic research shows

The University of Oklahoma College of Medicine did a controlled test and showed the odds of infection-related readmissions were decreased in the RTM group by 76% at 30 days, 80% at 60 days and 68% at ...

healthcareitnews.com

Check out our most recent work - A large database analysis of viral and fungal infections after CAR T cell therapy, published at @cmijournal.bsky.social, with @andhen25.bsky.social #IDSky #TxID www.clinicalmicrobiologyandinfection.com/article/S119...

First post on #IDSky We have an ID fellowship opening at the University of Oklahoma @ou.edu, starting July 2025. Two-year program, with great exposure to HIV, transplant ID and surgical infections, and above all, great people to train with! DM me for details! medicine.ouhsc.edu/academic-dep...